IDDF2019-ABS-0201 The clinical analysis of endoscopic treatment for non-varicose upper gastrointestinal bleeding

Background

To investigate the application value of endoscopic hemostatic therapy in treating nonvariceal upper gastrointestinal bleeding (NVUGIB).

Methods

90 patients with NVUGIB were selected in this research. According to the order of admission, 45 patients in the conventional group (January to June 2017) and 45 patients in the endoscopic group (July to December 2017) were respectively treated with conventional hemostasis and endoscopic hemostasis. Compare the therapeutic effects of the two treatment regimens.

Results

The hemostatic efficiency of the endoscopic group was 97.78% higher than that of the conventional group(X²=6.352, P<0.05). The length of hospital stay 9.56 d was shorter than that in the conventional group 15.94d, (t=14.005, P<0.05). The rate of rebleeding was 2.22% lower than that of the control group, (X²=8.607, P<0.05).

Conclusions

Endoscopic hemostasis for patients with NVUGIB can improve hemostasis efficiency, shorten the length of hospital stay, and effectively prevent re-bleeding.